<DOC>
	<DOCNO>NCT00252525</DOCNO>
	<brief_summary>CSP 465-B , Correlation Plasma Endothelial Cell ( Basic Fibroblast Growth Factor ) Activity With Cardiovascular Events Patients Diabetes Mellitus , Type II . Mark Zimering M.D . Objectives : Endothelial cell dysfunction play role development atherosclerotic vascular lesion also think provide mechanism increase urinary albumin excretion type 2 diabetes mellitus . Micro- macroalbuminuria associate increase cardiovascular ( CV ) morbidity mortality type 2 diabetes mellitus . In least one longitudinal study older-age onset patient , micro-or macroalbuminuria robustly predict increase CV risk independent diabetes-related factors.1 The pathogenetic mechanism underlie significant association micro- macroalbuminuria CV risk diabetes mellitus know may include : growth factor , clot factor , lipid , hemodynamic factor . The aim present study investigate whether angiogenic growth factor , basic fibroblast growth factor ( bFGF ) , plays role increase CV risk type 2 diabetes mellitus . Research Plan : BFGF ( FGF-2 ) one potent know angiogenesis factor . Increased bFGF previously associate endothelial cell injury micro- macroalbuminuria . In prior study 73 older-age onset veteran type 2 diabetes mellitus ( JCEM , 1996 ) , find plasma endothelial cell ( bFGF ) activity significantly associate glycemic level , ( multiple regression analysis ) independently associate microalbuminuria retinopathy . We test whether plasma endothelial cell ( bFGF ) activity significantly , independently associate pooled endpoint cardiovascular event include myocardial infarction ( MI ) , coronary revascularization , congestive heart failure ( CHF ) , CV mortality . We expect increase bFGF may robust marker increase CV risk diabetes mellitus three reason . First , bFGF independently associate ( micro ) -albuminuria type 2 diabetes mellitus . Second , increase bFGF associate increased activity renin-angiotensin system vascular smooth muscle cell ( Dzau , et al . JCI , 1995 ) . And third , ( report ) angiotensin convert enzyme inhibitor ( ACEi ) drug substantially decrease plasma bFGF level ( micro ) - albuminuric diabetes mellitus type 2 , ( others report ) ACEi drug substantially reduce risk development CHF patient LVH 2 , risk mortality MI ( 8,9 ) , risk CV death diabetic patient proteinuria . Because plasma endothelial cell ( bFGF ) activity correlate significantly glycemic level diabetes mellitus type 2 , plasma bFGF may one pathogenetic link glycemic level increase risk cardiovascular event diabetes mellitus , type 2 . Methods : Blood ( 3 mL EDTA plasma ) collect subject Years 1 , 2 Study 6 local participate VA substudy site . Because plasma endothelial cell ( bFGF-like ) bioactivity bFGFR-IR vivo stable month year base prior publish study ( 1-3 ) , anticipate obtain 2 specimen , 1 Years 1 , 2 study , provide sufficient data model proportional risk .</brief_summary>
	<brief_title>Correlation Plasma Endothelial Cell Activity With Cardiovascular Events Patients With Diabetes Mellitus Type 2</brief_title>
	<detailed_description>Primary Hypothesis : The aim present study investigate whether angiogenic growth factor , basic fibroblast growth factor ( bFGF ) , plays role increase CV risk type 2 diabetes mellitus . Secondary Hypotheses : Primary Outcomes : cardiovascular morbidity mortality Study Abstract : CSP 465-B , Correlation Plasma Endothelial Cell ( Basic Fibroblast Growth Factor ) Activity With Cardiovascular Events Patients Diabetes Mellitus , Type II . Mark Zimering M.D . Objectives : Endothelial cell dysfunction play role development atherosclerotic vascular lesion also think provide mechanism increase urinary albumin excretion type 2 diabetes mellitus . Micro- macroalbuminuria associate increase cardiovascular ( CV ) morbidity mortality type 2 diabetes mellitus . In least one longitudinal study older-age onset patient , micro-or macroalbuminuria robustly predict increase CV risk independent diabetes-related factors.1 The pathogenetic mechanism underlie significant association micro- macroalbuminuria CV risk diabetes mellitus know may include : growth factor , clot factor , lipid , hemodynamic factor . The aim present study investigate whether angiogenic growth factor , basic fibroblast growth factor ( bFGF ) , plays role increase CV risk type 2 diabetes mellitus . Research Plan : BFGF ( FGF-2 ) one potent know angiogenesis factor . Increased bFGF previously associate endothelial cell injury micro- macroalbuminuria . In prior study 73 older-age onset veteran type 2 diabetes mellitus ( JCEM , 1996 ) , find plasma endothelial cell ( bFGF ) activity significantly associate glycemic level , ( multiple regression analysis ) independently associate microalbuminuria retinopathy . We test whether plasma endothelial cell ( bFGF ) activity significantly , independently associate pooled endpoint cardiovascular event include myocardial infarction ( MI ) , coronary revascularization , congestive heart failure ( CHF ) , CV mortality . We expect increase bFGF may robust marker increase CV risk diabetes mellitus three reason . First , bFGF independently associate ( micro ) -albuminuria type 2 diabetes mellitus . Second , increase bFGF associate increased activity renin-angiotensin system vascular smooth muscle cell ( Dzau , et al . JCI , 1995 ) . And third , ( report ) angiotensin convert enzyme inhibitor ( ACEi ) drug substantially decrease plasma bFGF level ( micro ) - albuminuric diabetes mellitus type 2 , ( others report ) ACEi drug substantially reduce risk development CHF patient LVH 2 , risk mortality MI ( 8,9 ) , risk CV death diabetic patient proteinuria . Because plasma endothelial cell ( bFGF ) activity correlate significantly glycemic level diabetes mellitus type 2 , plasma bFGF may one pathogenetic link glycemic level increase risk cardiovascular event diabetes mellitus , type 2 . Methods : Blood ( 3 mL EDTA plasma ) collect subject Years 1 , 2 Study 6 local participate VA substudy site . Because plasma endothelial cell ( bFGF-like ) bioactivity bFGFR-IR vivo stable month year base prior publish study ( 1-3 ) , anticipate obtain 2 specimen , 1 Years 1 , 2 study , provide sufficient data model proportional risk . Results : One hundred five first cardiovascular event occur 399 subject . The best fit model risk factor associate time first CVD occurrence ( study ) seven one-half year period significant predictor : prior cardiovascular event [ hazard ratio ( HR ) 3.378 ; 95 % confidence interval ( CI ) 3.079-3.807 ; P &lt; 0.0001 ) , baseline plasma bFGF ( HR 1.008 ; 95 % CI 1.002-1.014 ; P D0.01 ) , age ( HR 1.027 ; 95 % CI 1.004-1.051 ; P D0.019 ) , baseline plasma triglyceride ( HR 1.001 ; 95 % CI 1.000-1.002 ; P D0.02 ) , diabetes duration-treatment interaction ( P D0.03 ) . Intensive glucose-lowering associate significantly decrease hazard ratio CVD occurrence ( 0.38-0.63 ) patient know diabetes duration 0-10 year , nonsignificantly increase hazard ratio CVD occurrence ( 0.82-1.78 ) patient longer diabetes duration . Conclusion : High level plasma bFGF predictive biomarker future CVD occurrence population adult type 2 diabetes . In conclusion , present finding suggest baseline plasma bFGF may marker CVD risk adult male veteran type2 diabetes . These result suggest increase plasma bFGF drive cell proliferation involve mechanism increase CVD occurrence older adult advance type2 diabetes mellitus . Main Manuscript : Basic fibroblast growth factor predict cardiovascular disease occurrence participant veterans affair diabetes trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type 2 DM longer responsive maximum dose one oral agent . Not part VADT .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>